Hexagon Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$474K Buy
1,308
+137
+12% +$46.9K 0.07% 144
2026
Q1
$412K Buy
+1,171
New +$417K 0.06% 148
2025
Q2
Sell
-2,669
Closed -$832K 156
2025
Q1
$832K Sell
2,669
-19
-0.7% -$5.61K 0.16% 67
2024
Q4
$701K Sell
2,688
-44
-2% -$13.1K 0.13% 75
2024
Q3
$880K Sell
2,732
-130
-5% -$42.5K 0.17% 58
2024
Q2
$894K Buy
2,862
+86
+3% +$25.3K 0.19% 55
2024
Q1
$789K Sell
2,776
-328
-11% -$96K 0.18% 62
2023
Q4
$894K Buy
3,104
+100
+3% +$27.2K 0.22% 44
2023
Q3
$807K Buy
3,004
+149
+5% +$37.2K 0.21% 43
2023
Q2
$634K Buy
2,855
+11
+0.4% +$2.55K 0.17% 57
2023
Q1
$688K Buy
2,844
+135
+5% +$33.1K 0.19% 50
2022
Q4
$712K Sell
2,709
-299
-10% -$80.2K 0.21% 53
2022
Q3
$678K Buy
3,008
+370
+14% +$89.7K 0.2% 56
2022
Q2
$642K Sell
2,638
-167
-6% -$40.9K 0.19% 66
2022
Q1
$678K Buy
2,805
+88
+3% +$20.2K 0.18% 68
2021
Q4
$611K Buy
2,717
+230
+9% +$48.5K 0.16% 74
2021
Q3
$529K Buy
2,487
+565
+29% +$130K 0.15% 75
2021
Q2
$468K Buy
1,922
+193
+11% +$47.5K 0.13% 82
2021
Q1
$430K Sell
1,729
-8
-0.5% -$1.91K 0.12% 75
2020
Q4
$399K Hold
1,737
0.12% 77
2020
Q3
$382K Buy
+1,737
New +$430K 0.12% 77

Other funds holding AMGN

Hexagon Capital Partners's AMGN Position: Q2 2026 in Review

Hexagon Capital Partners increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $46.9K and bringing the position to 1,308 shares worth $474K. The position accounts for 0.07% of the portfolio, ranked #144.

Hexagon Capital Partners first reported a position in AMGN in Q3 2020 and has held it in 21 quarters since. The position peaked at $894K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hexagon Capital Partners held 1,308 shares of Amgen worth $474K as of Q2 2026.
  • Hexagon Capital Partners bought 137 Amgen shares in Q2 2026, an estimated $46.9K.
  • Amgen made up 0.07% of Hexagon Capital Partners's portfolio in Q2 2026, its #144 holding.
  • Hexagon Capital Partners first reported a position in Amgen in Q3 2020 and has held it in 21 quarters since.
  • Hexagon Capital Partners's Amgen position peaked at $894K in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.